ALK and T-cell non-Hodgkin lymphoma: T-cell lymphomas are a heterogeneous group of diseases but are uniformly aggressive and respond poorly to our conventional chemotherapy, with the notable exception of ALK-positive anaplastic large cell lymphoma.